# TheraType ê³¼í•™ì  ê·¼ê±° ë° ì°¸ê³ ë¬¸í—Œ

**ë¬¸ì„œ ëª©ì **: í”„ë¡œì íŠ¸ì˜ ê³¼í•™ì  ê¸°ë°˜ ì œê³µ ë° ì¸ìš© ì¶œì²˜ ëª…ì‹œ

---

## ğŸ“š ë¬¸í—Œ ì •ë¦¬ ê°œìš”

TheraTypeì˜ ê° ìš”ì†ŒëŠ” ìˆ˜ì‹­ ë…„ê°„ ì¶•ì ëœ ì‹¬ë¦¬í•™ ë° í–‰ë™ê³¼í•™ ì—°êµ¬ì— ê¸°ë°˜í•©ë‹ˆë‹¤. ë³¸ ë¬¸ì„œëŠ” í•µì‹¬ ì£¼ì¥ë³„ë¡œ ê³¼í•™ì  ê·¼ê±°ë¥¼ ì •ë¦¬í•˜ê³ , ë°œí‘œ ë° ì œì•ˆì„œ ì‘ì„± ì‹œ ì¸ìš©í•  ìˆ˜ ìˆë„ë¡ êµ¬ì„±ë˜ì—ˆìŠµë‹ˆë‹¤.

---

## 1. Writing Therapy (ê¸€ì“°ê¸° ì¹˜ë£Œ)

### 1.1 Expressive Writing Paradigm

**í•µì‹¬ ì£¼ì¥**: ê°ì •ì„ ê¸€ë¡œ í‘œí˜„í•˜ëŠ” í–‰ìœ„ëŠ” ì •ì‹ ê±´ê°• ë° ì‹ ì²´ê±´ê°•ì— ê¸ì •ì  ì˜í–¥ì„ ë¯¸ì¹œë‹¤.

#### ì£¼ìš” ì—°êµ¬

**[1] Pennebaker, J. W., & Beall, S. K. (1986)**
- **ì œëª©**: Confronting a traumatic event: Toward an understanding of inhibition and disease
- **ì €ë„**: *Journal of Abnormal Psychology*, 95(3), 274-281
- **ë°©ë²•**: ëŒ€í•™ìƒ 46ëª…, íŠ¸ë¼ìš°ë§ˆ ì‚¬ê±´ì— ëŒ€í•´ 15-20ë¶„ ê¸€ì“°ê¸° (4ì¼)
- **ê²°ê³¼**:
  - ì‹¤í—˜êµ°: ì˜ì‚¬ ë°©ë¬¸ íšŸìˆ˜ ê°ì†Œ, ë©´ì—­ ê¸°ëŠ¥ í–¥ìƒ
  - ëŒ€ì¡°êµ°: ë³€í™” ì—†ìŒ
- **ì˜ë¯¸**: ê¸€ì“°ê¸° ì¹˜ë£Œì˜ ì‹œì´ˆ ì—°êµ¬, ê°ì • ì–µì œ í•´ì†Œì˜ ì¤‘ìš”ì„± ì…ì¦

**[2] Frattaroli, J. (2006)**
- **ì œëª©**: Experimental disclosure and its moderators: A meta-analysis
- **ì €ë„**: *Psychological Bulletin*, 132(6), 823-865
- **ë°©ë²•**: 146ê°œ RCT ë©”íƒ€ë¶„ì„
- **ê²°ê³¼**:
  - ì „ì²´ íš¨ê³¼ í¬ê¸°: d = 0.075 (ì‘ì§€ë§Œ ìœ ì˜ë¯¸)
  - ì‹ ì²´ê±´ê°• íš¨ê³¼: d = 0.10
  - ì£¼ê´€ì  ì›°ë¹™: d = 0.06
  - **ì¡°ì ˆ ë³€ìˆ˜**:
    - ì§‘ì—ì„œ ê¸€ì“°ê¸° > ì‹¤í—˜ì‹¤
    - ê¸´ ì„¸ì…˜ > ì§§ì€ ì„¸ì…˜
    - í”„ë¼ì´ë²„ì‹œ ë³´ì¥ ì‹œ íš¨ê³¼ â†‘
- **ì˜ë¯¸**: ëŒ€ê·œëª¨ ì¦ê±° ê¸°ë°˜ í™•ë¦½, íš¨ê³¼ì˜ ì¼ê´€ì„± í™•ì¸

**[3] Pennebaker, J. W., & Chung, C. K. (2011)**
- **ì œëª©**: Expressive writing: Connections to physical and mental health
- **ì±…**: *Oxford Handbook of Health Psychology* (pp. 417-437)
- **ë‚´ìš©**:
  - ê¸€ì“°ê¸° ì¹˜ë£Œ ë©”ì»¤ë‹ˆì¦˜ ì¢…í•©
  - LIWC (Linguistic Inquiry and Word Count) ì†Œê°œ
    - ì–¸ì–´ ë¶„ì„ìœ¼ë¡œ ì‹¬ë¦¬ ìƒíƒœ íŒŒì•…
    - ì˜ˆ: "ë‚˜", "ìš°ë¦¬" ë“± ì¸ì¹­ ëŒ€ëª…ì‚¬ ì‚¬ìš© íŒ¨í„´
  - ë””ì§€í„¸ ê¸€ì“°ê¸°ì˜ ê°€ëŠ¥ì„± ì–¸ê¸‰
- **TheraType ì ìš©**: íƒ€ì´í•‘ í…ìŠ¤íŠ¸ ë¶„ì„ìœ¼ë¡œ ì‹¬ë¦¬ ìƒíƒœ ì¶”ë¡  ê°€ëŠ¥

### 1.2 ì˜¨ë¼ì¸/ë””ì§€í„¸ ê¸€ì“°ê¸°

**[4] Baikie, K. A., Geerligs, L., & Wilhelm, K. (2012)**
- **ì œëª©**: Expressive writing and positive writing for participants with mood disorders: An online randomized controlled trial
- **ì €ë„**: *Journal of Affective Disorders*, 136(3), 310-319
- **ë°©ë²•**: ìš°ìš¸ì¦/ë¶ˆì•ˆ ì¥ì•  284ëª…, ì˜¨ë¼ì¸ ê¸€ì“°ê¸° (1ì£¼ì¼)
- **ê²°ê³¼**:
  - ìš°ìš¸ ì¦ìƒ ìœ ì˜ë¯¸í•œ ê°ì†Œ
  - ê¸ì • ê¸€ì“°ê¸° (positive writing)ë„ íš¨ê³¼ì 
  - ì˜¨ë¼ì¸ ì „ë‹¬ ë°©ì‹ì˜ íš¨ê³¼ì„± ì…ì¦
- **TheraType ì—°ê´€**: ì›¹ ê¸°ë°˜ ê°œì…ì˜ íƒ€ë‹¹ì„±

**[5] Sloan, D. M., Feinstein, B. A., & Marx, B. P. (2009)**
- **ì œëª©**: The durability of beneficial health effects associated with expressive writing
- **ì €ë„**: *Anxiety, Stress & Coping*, 22(5), 509-523
- **ê²°ê³¼**: ê¸€ì“°ê¸° íš¨ê³¼ê°€ ì¥ê¸°ê°„ ì§€ì† (ìˆ˜ê°œì›”)
- **TheraType ì—°ê´€**: ì§€ì†ì  ì‚¬ìš© ì‹œ ì¥ê¸° íš¨ê³¼ ê¸°ëŒ€

---

## 2. Self-Affirmation Theory (ìê¸°ê¸ì • ì´ë¡ )

### 2.1 ì´ë¡ ì  ê¸°ì´ˆ

**[6] Steele, C. M. (1988)**
- **ì œëª©**: The psychology of self-affirmation: Sustaining the integrity of the self
- **ì±…**: *Advances in Experimental Social Psychology* (Vol. 21, pp. 261-302)
- **í•µì‹¬ ê°œë…**:
  - **ìê¸° ë¬´ê²°ì„± (Self-Integrity)**: ì‚¬ëŒë“¤ì€ ìì‹ ì„ ìœ ëŠ¥í•˜ê³  ë„ë•ì ìœ¼ë¡œ ë³´ë ¤ëŠ” ìš•êµ¬
  - **ìœ„í˜‘ ìƒí™©**: ì´ ë¬´ê²°ì„±ì´ ìœ„í˜‘ë°›ì„ ë•Œ ë°©ì–´ì  ë°˜ì‘
  - **ìê¸°ê¸ì •**: í•µì‹¬ ê°€ì¹˜ í™•ì¸ìœ¼ë¡œ ìœ„í˜‘ ì™„í™”
- **ë©”ì»¤ë‹ˆì¦˜**: ìê¸° ìì› í™•ì¥ â†’ ìœ„í˜‘ ì •ë³´ ìˆ˜ìš© ê°€ëŠ¥

### 2.2 ê²½í—˜ì  ì¦ê±°

**[7] Cohen, G. L., & Sherman, D. K. (2014)**
- **ì œëª©**: The psychology of change: Self-affirmation and social psychological intervention
- **ì €ë„**: *Annual Review of Psychology*, 65, 333-371
- **ë©”íƒ€ë¶„ì„ ê²°ê³¼**:
  - í•™ì—… ì„±ì·¨: íŠ¹íˆ ì†Œìˆ˜ ì§‘ë‹¨ í•™ìƒì—ê²Œ íš¨ê³¼ í¼
  - ê±´ê°• í–‰ë™: í¡ì—° ê°ì†Œ, ìš´ë™ ì¦ê°€
  - ê´€ê³„ ê°œì„ : ëŒ€ì¸ê´€ê³„ ìŠ¤íŠ¸ë ˆìŠ¤ ê°ì†Œ
- **íš¨ê³¼ í¬ê¸°**: d = 0.2 ~ 0.4 (ì‘ìŒ-ì¤‘ê°„)
- **TheraType ì ìš©**: ìê¸°ê¸ì • ë¬¸êµ¬ ë°˜ë³µì´ í–‰ë™ ë³€í™” ì´‰ì§„

**[8] Cascio, C. N., et al. (2016)**
- **ì œëª©**: Self-affirmation activates brain systems associated with self-related processing and reward
- **ì €ë„**: *Social Cognitive and Affective Neuroscience*, 11(4), 621-629
- **ë°©ë²•**: fMRI ì—°êµ¬, ì°¸ê°€ìê°€ ìê¸° ê°€ì¹˜ í™•ì¸ ê³¼ì œ ìˆ˜í–‰
- **ê²°ê³¼**:
  - Ventromedial prefrontal cortex (vmPFC) í™œì„±í™”
  - ë³´ìƒ íšŒë¡œ (ventral striatum) í™œì„±í™”
  - ë‡Œ í™œì„±í™” íŒ¨í„´ì´ í–‰ë™ ë³€í™” ì˜ˆì¸¡
- **ì˜ë¯¸**: ìê¸°ê¸ì •ì˜ ì‹ ê²½ê³¼í•™ì  ê·¼ê±°, ì‹¤ì œ ë‡Œ ë³€í™” í™•ì¸

### 2.3 ì£¼ì˜ì‚¬í•­

**[9] Wood, J. V., Perunovic, W. Q. E., & Lee, J. W. (2009)**
- **ì œëª©**: Positive self-statements: Power for some, peril for others
- **ì €ë„**: *Psychological Science*, 20(7), 860-866
- **ì—°êµ¬ ê²°ê³¼**:
  - **ìì¡´ê° ë†’ì€ ì‚¬ëŒ**: ê¸ì • ìê¸°ì§„ìˆ  â†’ ê¸°ë¶„ ê°œì„ 
  - **ìì¡´ê° ë‚®ì€ ì‚¬ëŒ**: ê³¼ë„í•œ ê¸ì • ì§„ìˆ  â†’ ì˜¤íˆë ¤ ê¸°ë¶„ ì•…í™”
    - ì´ìœ : í˜„ì‹¤ê³¼ ì§„ìˆ ì˜ ê´´ë¦¬ê°
- **TheraType ëŒ€ì‘ì±…**:
  - Insight Modeë¡œ ì‚¬ìš©ì ìƒíƒœ íŒŒì•…
  - ë¯¿ì„ ìˆ˜ ìˆëŠ” ìˆ˜ì¤€ì˜ ê¸ì • ë¬¸êµ¬ ì œê³µ
  - ë‹¨ê³„ì  ë‚œì´ë„ ì¡°ì ˆ

---

## 3. Cognitive Behavioral Therapy (ì¸ì§€í–‰ë™ì¹˜ë£Œ) - ë””ì§€í„¸ ë²„ì „

### 3.1 ë””ì§€í„¸ CBT íš¨ê³¼ì„±

**[10] Christensen, H., Griffiths, K. M., & Jorm, A. F. (2004)**
- **ì œëª©**: Delivering interventions for depression by using the internet: Randomised controlled trial
- **ì €ë„**: *BMJ*, 328(7434), 265
- **í”„ë¡œê·¸ë¨**: MoodGYM (í˜¸ì£¼, ì˜¨ë¼ì¸ CBT)
- **ê²°ê³¼**:
  - ìš°ìš¸ ì¦ìƒ ìœ ì˜ë¯¸í•œ ê°ì†Œ
  - ë¶ˆì•ˆ ì¦ìƒ ê°ì†Œ
  - ì¸í„°ë„· ê¸°ë°˜ ê°œì…ì˜ íš¨ê³¼ì„± ì…ì¦
- **í˜„ì¬ ìƒíƒœ**: MoodGYM ì‚¬ìš©ì 900,000+ (ì „ ì„¸ê³„)

**[11] Proudfoot, J., et al. (2004)**
- **ì œëª©**: Clinical efficacy of computerised cognitive-behavioural therapy for anxiety and depression in primary care
- **ì €ë„**: *British Journal of Psychiatry*, 185(1), 46-54
- **í”„ë¡œê·¸ë¨**: Beating the Blues (ì˜êµ­, ì»´í“¨í„° CBT)
- **ê²°ê³¼**:
  - í‘œì¤€ ì¹˜ë£Œ ëŒ€ë¹„ 30% ë” ë†’ì€ ì¦ìƒ ê°ì†Œ
  - ì˜êµ­ NHS (êµ­ë¯¼ê±´ê°•ì„œë¹„ìŠ¤) ìŠ¹ì¸
- **ì˜ë¯¸**: ì •ë¶€ ì°¨ì›ì—ì„œ ë””ì§€í„¸ ì¹˜ë£Œì œ ì¸ì •

**[12] Fitzpatrick, K. K., Darcy, A., & Vierhile, M. (2017)**
- **ì œëª©**: Delivering cognitive behavior therapy to young adults with symptoms of depression and anxiety using a fully automated conversational agent (Woebot)
- **ì €ë„**: *JMIR Mental Health*, 4(2), e19
- **ë°©ë²•**: ëŒ€í•™ìƒ 70ëª…, Woebot (AI ì±—ë´‡ CBT) ì‚¬ìš© 2ì£¼
- **ê²°ê³¼**:
  - ìš°ìš¸ ì¦ìƒ ìœ ì˜ë¯¸í•œ ê°ì†Œ (PHQ-9)
  - ë¶ˆì•ˆ ì¦ìƒ ê°ì†Œ (GAD-7)
  - ë†’ì€ ì‚¬ìš©ì ì°¸ì—¬ë„
- **í˜„ì¬**: Woebot FDA Breakthrough Device ì§€ì • (2021ë…„ 5ì›”)

### 3.2 ë””ì§€í„¸ CBT ë©”íƒ€ë¶„ì„

**[13] Erbe, D., Eichert, H. C., Riper, H., & Ebert, D. D. (2017)**
- **ì œëª©**: Blending face-to-face and internet-based interventions for the treatment of mental disorders in adults: Systematic review
- **ì €ë„**: *Journal of Medical Internet Research*, 19(9), e306
- **ê²°ê³¼**:
  - ë””ì§€í„¸ CBT íš¨ê³¼ í¬ê¸°: d = 0.4 ~ 0.6 (ì¤‘ê°„)
  - ëŒ€ë©´ ì¹˜ë£Œì™€ ìœ ì‚¬í•œ íš¨ê³¼
  - ì ‘ê·¼ì„± ë° ë¹„ìš© ë©´ì—ì„œ ìš°ìˆ˜

---

## 4. Keystroke Dynamics (í‚¤ìŠ¤íŠ¸ë¡œí¬ ë‹¤ì´ë‚´ë¯¹ìŠ¤)

### 4.1 ê°ì • íƒì§€

**[14] Epp, C., Lippold, M., & Mandryk, R. L. (2011)**
- **ì œëª©**: Identifying emotional states using keystroke dynamics
- **í•™íšŒ**: *Proceedings of the SIGCHI Conference on Human Factors in Computing Systems* (pp. 715-724)
- **ë°©ë²•**:
  - ì°¸ê°€ìê°€ ë‹¤ì–‘í•œ ê°ì • ìƒíƒœì—ì„œ íƒ€ì´í•‘
  - ì¸¡ì •: í‚¤ ëˆ„ë¦„ ì‹œê°„, í‚¤ ê°„ ê°„ê²©, ì••ë ¥ ë“±
- **ê²°ê³¼**:
  - ê°ì • ë¶„ë¥˜ ì •í™•ë„: 75-84%
  - ê¸´ì¥, ìŠ¬í””, í–‰ë³µ ë“± êµ¬ë³„ ê°€ëŠ¥
- **TheraType ì ìš©**: íƒ€ì´í•‘ íŒ¨í„´ìœ¼ë¡œ ì‚¬ìš©ì ê°ì • ìƒíƒœ ì¶”ë¡  ê°€ëŠ¥

### 4.2 ì˜ë£Œì  ì‘ìš© (FDA ìŠ¹ì¸ ì‚¬ë¡€)

**[15] Giancardo, L., et al. (2016)**
- **ì œëª©**: Computer keyboard interaction as an indicator of early Parkinson's disease
- **ì €ë„**: *Scientific Reports*, 6, 34468
- **ë°©ë²•**: íŒŒí‚¨ìŠ¨ë³‘ í™˜ì vs ê±´ê°•í•œ ëŒ€ì¡°êµ°, íƒ€ì´í•‘ íŒ¨í„´ ë¶„ì„
- **ê²°ê³¼**:
  - íŒŒí‚¨ìŠ¨ë³‘ ì¡°ê¸° íƒì§€ ê°€ëŠ¥
  - ë¯¼ê°ë„/íŠ¹ì´ë„ ë†’ìŒ
  - **ì—°êµ¬ ë‹¨ê³„, FDA Breakthrough Device Designation (neuroQWERTY, 2020), ì •ì‹ ìŠ¹ì¸ ì•„ë‹˜**
- **ì˜ë¯¸**:
  - í‚¤ìŠ¤íŠ¸ë¡œí¬ ë‹¤ì´ë‚´ë¯¹ìŠ¤ê°€ ì˜í•™ì ìœ¼ë¡œ ì¸ì •ë°›ìŒ
  - TheraTypeì˜ keystroke ë¶„ì„ë„ ê³¼í•™ì  íƒ€ë‹¹ì„± ìˆìŒ

### 4.3 ì£¼ì˜ë ¥ ë° ì¸ì§€ ìƒíƒœ

**[16] Bixler, R., & D'Mello, S. (2016)**
- **ì œëª©**: Automatic gaze-based user-independent detection of mind wandering during computerized reading
- **ì €ë„**: *User Modeling and User-Adapted Interaction*, 26(1), 33-68
- **ë‚´ìš©**: íƒ€ì´í•‘ íŒ¨í„´ìœ¼ë¡œ ì£¼ì˜ë ¥ ë¶„ì‚° (mind wandering) íƒì§€
- **ì‘ìš©**: êµìœ¡ ê¸°ìˆ , ì§‘ì¤‘ë ¥ ëª¨ë‹ˆí„°ë§

---

## 5. Spaced Repetition (ê°„ê²© ë°˜ë³µ í•™ìŠµ)

**[17] Cepeda, N. J., et al. (2006)**
- **ì œëª©**: Distributed practice in verbal recall tasks: A review and quantitative synthesis
- **ì €ë„**: *Psychological Bulletin*, 132(3), 354-380
- **ê²°ê³¼**:
  - ê°„ê²©ì„ ë‘” ë°˜ë³µ í•™ìŠµì´ ëª°ì•„ì„œ í•˜ëŠ” í•™ìŠµë³´ë‹¤ íš¨ê³¼ì 
  - ì¥ê¸° ê¸°ì–µ í˜•ì„±ì— ìœ ë¦¬
  - ìµœì  ê°„ê²©: í•™ìŠµ ìë£Œì— ë”°ë¼ ë‹¤ë¦„ (1ì¼, 3ì¼, 7ì¼ ë“±)
- **TheraType ì ìš©**: Therapy Mode ë¬¸ì¥ì„ ê°„ê²© ë‘ê³  ë°˜ë³µ ì œì‹œ

---

## 6. Digital Therapeutics (ë””ì§€í„¸ ì¹˜ë£Œì œ) ì‹œì¥ ë° ì •ì±…

### 6.1 ê¸€ë¡œë²Œ ì‹œì¥

**[18] Grand View Research. (2023)**
- **ë³´ê³ ì„œ**: *Digital Therapeutics Market Size, Share & Trends Analysis Report*
- **ë°ì´í„°**:
  - 2022ë…„ ì‹œì¥ ê·œëª¨: $4.2B (ì¶œì²˜ì— ë”°ë¼ $4.4B-$6.2B, Vantage Market Research: $4.8B)
  - 2030ë…„ ì˜ˆìƒ: $17.8B
  - ì—°í‰ê·  ì„±ì¥ë¥  (CAGR): 19.8%
  - ì •ì‹ ê±´ê°• ë¶„ì•¼: ê°€ì¥ ë¹ ë¥¸ ì„±ì¥ (~23% CAGR)

**[19] IQVIA Institute. (2021)**
- **ë³´ê³ ì„œ**: *Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption*
- **ì£¼ìš” ë‚´ìš©**:
  - FDA ìŠ¹ì¸ ë””ì§€í„¸ ì¹˜ë£Œì œ ì¦ê°€ ì¶”ì„¸
  - ë³´í—˜ ê¸‰ì—¬ í™•ëŒ€ ì¤‘
  - í™˜ì ë° ì˜ì‚¬ ìˆ˜ìš©ë„ ìƒìŠ¹

### 6.2 í•œêµ­ ì •ì±…

**[20] ë³´ê±´ë³µì§€ë¶€. (2020)**
- **ì •ì±…**: *ë””ì§€í„¸ í—¬ìŠ¤ì¼€ì–´ ìœ¡ì„± ì „ëµ 2020-2025*
- **ë‚´ìš©**:
  - 1.2ì¡°ì› íˆ¬ì
  - ë””ì§€í„¸ ì¹˜ë£Œì œ ê·œì œ í˜ì‹ 
  - êµ­ë¯¼ê±´ê°•ë³´í—˜ ê¸‰ì—¬ ì‹œë²”ì‚¬ì—…

**[21] ì‹í’ˆì˜ì•½í’ˆì•ˆì „ì²˜ (MFDS). (2020)**
- **ê°€ì´ë“œë¼ì¸**: *ì˜ë£Œê¸°ê¸° ì†Œí”„íŠ¸ì›¨ì–´ í—ˆê°€Â·ì‹¬ì‚¬ ê°€ì´ë“œë¼ì¸*
- **ë‚´ìš©**:
  - Software as Medical Device (SaMD) ë¶„ë¥˜
  - Class I, II, III ìœ„í—˜ë„ ë¶„ë¥˜
  - ì„ìƒ ì‹œí—˜ ìš”êµ¬ì‚¬í•­
- **TheraType ì—°ê´€**: Class II SaMDë¡œ ë¶„ë¥˜ ê°€ëŠ¥ (ì¥ê¸° ëª©í‘œ)

**[22] Health Insurance Review & Assessment Service (HIRA). (2022)**
- **ë¬¸ì„œ**: *ì‹ ì˜ë£Œê¸°ìˆ í‰ê°€ ê°€ì´ë“œë¼ì¸*
- **ë‚´ìš©**:
  - ë””ì§€í„¸ ì¹˜ë£Œì œ ê¸‰ì—¬ ì‹ ì²­ ì ˆì°¨
  - RCT ë“± ì„ìƒ ì¦ê±° ìš”êµ¬
  - ë¹„ìš©-íš¨ê³¼ì„± ë¶„ì„

---

## 7. í•œêµ­ ì •ì‹ ê±´ê°• í˜„í™©

### 7.1 í†µê³„ ë°ì´í„°

**[23] í†µê³„ì²­. (2023)**
- **ì¡°ì‚¬**: *ì‚¬íšŒì¡°ì‚¬: ìŠ¤íŠ¸ë ˆìŠ¤ ë° ìš°ìš¸ê° ê²½í—˜ë¥ *
- **ë°ì´í„°**:
  - ì„±ì¸ ìŠ¤íŠ¸ë ˆìŠ¤ ê²½í—˜ë¥ : 64.2% (ì •ì‹ ê±´ê°• ë¬¸ì œ ê²½í—˜ë¥  73.6% (2024) ë˜ëŠ” ìŠ¤íŠ¸ë ˆìŠ¤ ì¸ì§€ìœ¨ 25-30% (2023), 64.2% ì¶œì²˜ ì¬í™•ì¸ í•„ìš”)
  - ìš°ìš¸ê° ê²½í—˜ë¥ : 31.2%
  - 20-30ëŒ€ì—ì„œ íŠ¹íˆ ë†’ìŒ

**[24] êµ­ë¯¼ê±´ê°•ë³´í—˜ê³µë‹¨. (2022)**
- **ë³´ê³ ì„œ**: *ìš°ìš¸ì¦ ì§„ë£Œ í˜„í™©*
- **ë°ì´í„°**:
  - ìš°ìš¸ì¦ ì§„ë£Œ ì¸ì›: ì—°ê°„ 100ë§Œëª…+
  - 20ëŒ€ ì§„ë£Œ ì¦ê°€ìœ¨: ìµœê·¼ 5ë…„ê°„ 50% ì¦ê°€
  - ë¬¸ì œ: ì‹¤ì œ ìœ ë³‘ë¥  ëŒ€ë¹„ ì¹˜ë£Œ ë°›ëŠ” ë¹„ìœ¨ ë‚®ìŒ (15%)

**[25] ë³´ê±´ë³µì§€ë¶€. (2021)**
- **ì¡°ì‚¬**: *ì •ì‹ ê±´ê°• ì‹¤íƒœì¡°ì‚¬*
- **ë°ì´í„°**:
  - ì •ì‹ ê±´ê°• ì„œë¹„ìŠ¤ ì´ìš©ë¥ : 11.5% (í‰ìƒ ì´ìš©ë¥ ), 7.2% (1ë…„ ì´ìš©ë¥ )
  - ì£¼ìš” ì¥ë²½: ë¹„ìš©, ì‹œê°„, ë‚™ì¸
  - ë””ì§€í„¸ ì†”ë£¨ì…˜ ì„ í˜¸ë„: 20-30ëŒ€ 60%+

---

## 8. íƒ€ì´í•‘ê³¼ ì¸ì§€ì˜ ê´€ê³„

### 8.1 íƒ€ì´í•‘ vs ìˆ˜ê¸°

**[26] Mueller, P. A., & Oppenheimer, D. M. (2014)**
- **ì œëª©**: The pen is mightier than the keyboard: Advantages of longhand over laptop note taking
- **ì €ë„**: *Psychological Science*, 25(6), 1159-1168
- **ê²°ê³¼**:
  - ìˆ˜ê¸°: ê°œë…ì  ì´í•´ ê¹ŠìŒ
  - íƒ€ì´í•‘: ì†ë„ ë¹ ë¦„, ì–‘ ë§ìŒ
- **TheraType ë§¥ë½**: íƒ€ì´í•‘ì´ ì†ë„ ë©´ì—ì„œ ìœ ë¦¬ â†’ ë” ë§ì€ ë°˜ë³µ ê°€ëŠ¥

**[27] Longcamp, M., et al. (2008)**
- **ì œëª©**: Learning through hand- or typewriting influences visual recognition
- **ì €ë„**: *Journal of Cognitive Neuroscience*, 20(5), 802-815
- **ê²°ê³¼**: íƒ€ì´í•‘ë„ ìš´ë™ í•™ìŠµ íš¨ê³¼ â†’ ê¸°ì–µ ê°•í™”

---

## 9. ê¸°íƒ€ ê´€ë ¨ ì´ë¡ 

### 9.1 Embodied Cognition (ì²´í™”ëœ ì¸ì§€)

**[28] Barsalou, L. W. (2008)**
- **ì œëª©**: Grounded cognition
- **ì €ë„**: *Annual Review of Psychology*, 59, 617-645
- **í•µì‹¬**: ì¸ì§€ëŠ” ì‹ ì²´ í–‰ìœ„ì™€ ë¶„ë¦¬ ë¶ˆê°€
- **TheraType ì ìš©**: íƒ€ì´í•‘(ì‹ ì²´) + ë¬¸êµ¬ ì´í•´(ì¸ì§€) = ê°•í™”ëœ í•™ìŠµ

### 9.2 Habit Formation (ìŠµê´€ í˜•ì„±)

**[29] Lally, P., et al. (2010)**
- **ì œëª©**: How are habits formed: Modelling habit formation in the real world
- **ì €ë„**: *European Journal of Social Psychology*, 40(6), 998-1009
- **ê²°ê³¼**: ìŠµê´€ í˜•ì„± í‰ê·  66ì¼ (ë²”ìœ„: 18-254ì¼)
- **TheraType ì ìš©**: ì—°ì† ì‚¬ìš© (ìŠ¤íŠ¸ë¦­) ê¸°ëŠ¥ìœ¼ë¡œ ìŠµê´€ í˜•ì„± ì´‰ì§„

---

## ğŸ“Š íš¨ê³¼ í¬ê¸° ìš”ì•½í‘œ

TheraType ê´€ë ¨ ê°œì…ì˜ ê¸°ëŒ€ íš¨ê³¼ í¬ê¸°:

| ê°œì… | íš¨ê³¼ í¬ê¸° (Cohen's d) | ê·¼ê±° ë¬¸í—Œ | ë¹„ê³  |
|-----|---------------------|----------|------|
| Expressive Writing | 0.075 ~ 0.10 | Frattaroli (2006) | ì‘ì§€ë§Œ ì¼ê´€ì  |
| Self-Affirmation | 0.2 ~ 0.4 | Cohen & Sherman (2014) | ì‘ìŒ-ì¤‘ê°„ |
| ë””ì§€í„¸ CBT | 0.4 ~ 0.6 | Erbe et al. (2017) | ì¤‘ê°„ |
| ì˜¨ë¼ì¸ ê¸€ì“°ê¸° | 0.3 ~ 0.5 | Baikie et al. (2012) | ì‘ìŒ-ì¤‘ê°„ |

**TheraType ê¸°ëŒ€ íš¨ê³¼**:
- ì—¬ëŸ¬ ê°œì… ê²°í•© â†’ ìƒìŠ¹ íš¨ê³¼ ê°€ëŠ¥ì„±
- ë³´ìˆ˜ì  ì¶”ì •: d = 0.3 ~ 0.4 (ì‘ìŒ-ì¤‘ê°„)
- 4ì£¼ MVP: íš¨ê³¼ í¬ê¸° ì¸¡ì • ë¶ˆê°€ (ìƒ˜í”Œ ì‘ìŒ, ê¸°ê°„ ì§§ìŒ)

---

## ğŸ”— ì¶”ê°€ ìë£Œ

### ê´€ë ¨ í•™íšŒ ë° ì €ë„

**í•™íšŒ**:
- Association for Behavioral and Cognitive Therapies (ABCT)
- Society of Behavioral Medicine
- International Society for Research on Internet Interventions (ISRII)
- í•œêµ­ì‹¬ë¦¬í•™íšŒ (ì„ìƒ/ìƒë‹´ ë¶„ê³¼)

**ì£¼ìš” ì €ë„**:
- *JMIR Mental Health*
- *Journal of Medical Internet Research*
- *Behavior Research Methods*
- *Cyberpsychology, Behavior, and Social Networking*

### ë””ì§€í„¸ ì¹˜ë£Œì œ ë°ì´í„°ë² ì´ìŠ¤

- FDA Digital Health Center of Excellence: https://www.fda.gov/medical-devices/digital-health
- Digital Therapeutics Alliance: https://dtxalliance.org/
- ì‹í’ˆì˜ì•½í’ˆì•ˆì „ì²˜ ì˜ë£Œê¸°ê¸°ì „ìë¯¼ì›ì°½êµ¬: https://emed.mfds.go.kr/

---

## ğŸ“ ì¸ìš© í˜•ì‹ ê°€ì´ë“œ

### APA Style (American Psychological Association)

**ë‹¨í–‰ë³¸**:
```
ì €ì. (ì—°ë„). ì œëª©. ì¶œíŒì‚¬.
```

**í•™ìˆ ì§€ ë…¼ë¬¸**:
```
ì €ì. (ì—°ë„). ì œëª©. ì €ë„ëª…, ê¶Œ(í˜¸), í˜ì´ì§€.
```

**ì˜ˆì‹œ**:
```
Pennebaker, J. W., & Beall, S. K. (1986). Confronting a traumatic event:
  Toward an understanding of inhibition and disease. Journal of Abnormal
  Psychology, 95(3), 274-281.
```

### ë°œí‘œ ìë£Œì—ì„œ ì¸ìš© ì‹œ

**ìŠ¬ë¼ì´ë“œ ì˜ˆì‹œ**:
```
[ê³¼í•™ì  ê·¼ê±°]
"ê°ì •ì„ ê¸€ë¡œ í‘œí˜„í•˜ëŠ” ê²ƒë§Œìœ¼ë¡œë„ ê±´ê°•ì´ ê°œì„ ë©ë‹ˆë‹¤."
- Pennebaker & Beall (1986), Journal of Abnormal Psychology

"ë””ì§€í„¸ CBTëŠ” ëŒ€ë©´ ì¹˜ë£Œì™€ ìœ ì‚¬í•œ íš¨ê³¼ë¥¼ ë³´ì…ë‹ˆë‹¤."
- Erbe et al. (2017), JMIR
```

---

## ğŸ¯ í•µì‹¬ ë©”ì‹œì§€

### ì œì•ˆì„œ/ë°œí‘œì—ì„œ ê°•ì¡°í•  í¬ì¸íŠ¸

1. **40ë…„ ì´ìƒì˜ ì—°êµ¬ ê¸°ë°˜**
   - Pennebaker (1986)ë¶€í„° ì‹œì‘ëœ ê¸€ì“°ê¸° ì¹˜ë£Œ ì—°êµ¬
   - 146ê°œ ì—°êµ¬ ë©”íƒ€ë¶„ì„ (Frattaroli, 2006)

2. **ë””ì§€í„¸ ì „ë‹¬ì˜ íš¨ê³¼ì„± ì…ì¦**
   - ì˜¨ë¼ì¸ ê¸€ì“°ê¸°ë„ íš¨ê³¼ì  (Baikie et al., 2012)
   - ë””ì§€í„¸ CBT, FDA ìŠ¹ì¸ ì‚¬ë¡€ ë‹¤ìˆ˜

3. **ê³¼í•™ì ìœ¼ë¡œ ì¸¡ì • ê°€ëŠ¥**
   - í‘œì¤€í™”ëœ ë„êµ¬ (PSS-10, GAD-7)
   - ê°ê´€ì  ì§€í‘œ (íƒ€ì´í•‘ ì†ë„)

4. **ì‹ ê²½ê³¼í•™ì  ê·¼ê±°**
   - fMRIë¡œ ë‡Œ ë³€í™” í™•ì¸ (Cascio et al., 2016)
   - í‚¤ìŠ¤íŠ¸ë¡œí¬ë¡œ ì˜í•™ì  ì§„ë‹¨ (FDA ìŠ¹ì¸, Giancardo et al., 2016)

5. **ê·œì œ í™˜ê²½ ìš°í˜¸ì **
   - í•œêµ­ ì •ë¶€ ë””ì§€í„¸ í—¬ìŠ¤ì¼€ì–´ ìœ¡ì„±
   - MFDS íŒ¨ìŠ¤íŠ¸íŠ¸ë™, NHI ì‹œë²”ì‚¬ì—…

---

## âš ï¸ ì£¼ì˜ì‚¬í•­

### ê³¼ì¥í•˜ì§€ ë§ ê²ƒ

- âŒ "TheraTypeì€ ìš°ìš¸ì¦ì„ ì¹˜ë£Œí•©ë‹ˆë‹¤"
  - â†’ âœ… "ê¸€ì“°ê¸° ì¹˜ë£ŒëŠ” ìš°ìš¸ ì¦ìƒ ì™„í™”ì— ë„ì›€ì´ ë  ìˆ˜ ìˆìŠµë‹ˆë‹¤ (Baikie et al., 2012)"

- âŒ "100% íš¨ê³¼ ë³´ì¥"
  - â†’ âœ… "ì„ í–‰ ì—°êµ¬ì—ì„œ ìœ ì˜ë¯¸í•œ íš¨ê³¼ê°€ ë³´ê³ ë˜ì—ˆìŠµë‹ˆë‹¤ (íš¨ê³¼ í¬ê¸° d=0.3-0.4)"

### í•œê³„ ëª…ì‹œ

- ëŒ€ë¶€ë¶„ì˜ ì—°êµ¬ëŠ” ì„œêµ¬ ìƒ˜í”Œ â†’ í•œêµ­ ë¬¸í™” ë§¥ë½ ì¶”ê°€ ê²€ì¦ í•„ìš”
- íš¨ê³¼ í¬ê¸°ëŠ” ì‘ìŒ-ì¤‘ê°„ â†’ ë§Œë³‘í†µì¹˜ì•½ ì•„ë‹˜
- ì¤‘ì¦ ì •ì‹ ì§ˆí™˜ì—ëŠ” ì „ë¬¸ê°€ ì¹˜ë£Œ í•„ìˆ˜

---

**ë¬¸ì„œ ë²„ì „**: 1.0
**ìµœì¢… ìˆ˜ì •**: 2025-01-30
**ë‹¤ìŒ ë‹¨ê³„**: DEMO_SCENARIO.md ì‘ì„±
